Alchemia teams with Belgian screening company
03 April, 2002 by Melissa TrudingerAustralian company Alchemia has begun a drug discovery collaboration with Belgium's Euroscreen.
New blow for Amrad as collaborators pull out
03 April, 2002 by Tanya HollisTwo early-stage research projects will revert back to the Amrad Corporation (ASX: AML) fold after collaborators decided they no longer wished to pursue them.
Takara spins off biotech unit
02 April, 2002 by Martyn WilliamsJapanese liquor maker Takara Shuzo has stepped up its push to make a name for itself in the biotechnology sector by separating its bio-related activities into a new company.
Cochlear hearing aid approved
02 April, 2002 by Daniella GoldbergListening device maker Cochlear has received approval from the Therapeutic Goods Administration (TGA) for sale of its ESPrit 3G in Australia, after gaining approval to sell in the US market last week.
Progen, Griffith team up in heparanase project
28 March, 2002 by Pete YoungQueensland private sector and academic researchers will share an Australian Research Council grant to probe an enyzme that plays a role in cancer and inflammatory diseases.
VC urges more pharma biotech commitment
28 March, 2002 by Pete YoungThe time is ripe to insist multinational pharmaceuticals lift their commitment to the local life sciences industry, claims venture capitalist Dr Geoff Brooke.
Cloned calves a first for Australia
27 March, 2002 by Melissa TrudingerIn a first for the Australian dairy industry, four genetically modified calves have been born with an additional protein gene for milk protein production.
Metabolic in trans-Tasman licensing, research deal
27 March, 2002 by Tanya HollisMetabolic Pharmaceuticals has announced a trans-Tasman licensing deal and research collaboration to develop a new osteoporosis treatment.
Xenome in third screening partnership
27 March, 2002 by Pete YoungBrisbane biotech and animal venom specialist Xenome Ltd has found yet another partner to screen its library of bioactive peptide molecules.
Victorian plant genetics company launched
26 March, 2002 by Tanya HollisMost of Australia's staple foods would be altered through genetic technologies within the next 20 years, according to one of the nation's most celebrated scientists.
Cyclotide research looks for new drugs
26 March, 2002 by Melissa TrudingerCyclotides are a unique group of plant proteins with unusual properties. Kalthera, a small Queensland biotech company, is developing technology to use them in therapeutic applications.
BASF Boosts Bioagriculture
26 March, 2002 by Daniella GoldbergAustralia's biotechnology industry may be in for a big boost after a team from BASF, an international plant and chemical company, visited to find potential collaborative ventures.
Hep C treatment targeted
25 March, 2002 by Tanya HollisThe US subsidiary of homegrown drug discovery group Biota Holdings has announced plans to focus on treatments for hepatitis C virus.
Bioprospecting company on the move
22 March, 2002 by Pete YoungBioProspect is expanding its beachead in Queensland on the back of promising results from its five-month-old biota mining agreement with the State Government.
Metabolic in iron drug deal
21 March, 2002 by Melissa TrudingerMelbourne biotechnology company Metabolic Pharmaceuticals (ASX:MBP) has entered into licence and research agreements with Sydney's Heart Research Institute (HRI) to develop a drug for the treatment of iron overload diseases.
